SILA REALTY TRUST INC

Company Overview

Sila Realty Trust, Inc. is an internally managed Maryland REIT focused on acquiring, owning and financing healthcare real estate leased primarily on long-term, net leases to creditworthy operators. As of year-end 2024 it owned 135 healthcare properties (two land parcels) and grew via eight acquisitions (~307k RSF, ~$164.1M) while completing an NYSE listing in June 2024 and a ~$50M Dutch-tender share repurchase. Key quantitative drivers include high portfolio occupancy (96% in 2024, 99.2% in Q2 2025), FFO/AFFO metrics (FFO $118.2M in 2024; AFFO ~$131.1M in 2024; Q2 2025 FFO ~$30M), a meaningful tenant concentration (Post Acute Medical ~14.9% of 2024 rental revenue), and substantial secured/unsecured financing and hedging positions.

Executive Compensation Practices

Given Sila’s REIT structure and internal management model, executive pay is likely weighted toward base salary plus performance-linked equity and cash incentives tied to FFO/AFFO, same-store rental revenue/NOI, occupancy/leasing metrics, and maintenance of REIT qualification (distribution policy). The June 2024 NYSE listing almost certainly introduced or expanded equity-based awards (restricted stock, PSUs or options) and formal performance metrics tied to total shareholder return, per-share FFO or portfolio growth to align management with public investors and reduce dilution after the reverse split and tender. Compensation committees will also factor in balance-sheet targets (leverage, covenant compliance, hedging effectiveness) because material financing outcomes and derivative cross-default exposure materially affect distributable cash and covenant-based covenants. Expect clawback provisions, holding requirements and multi-year vesting schedules to preserve alignment given the asset-heavy, cyclical nature of healthcare real estate.

Insider Trading Considerations

Insider trading activity at Sila will be sensitive to deal-driven events (acquisitions, dispositions, mezzanine loan originations), material tenant developments (tenant bankruptcies, lease amendments—e.g., GenesisCare, Steward, Post Acute Medical exposure), and funding/covenant disclosures because those items move FFO, AFFO and perceived dividend sustainability. The 2024 NYSE listing increased reporting frequency and liquidity, so insiders must comply with Section 16 reporting (Forms 3/4/5), exchange reporting rules, and usual blackout periods around earnings and material events; many insiders will use 10b5‑1 plans or pre-clearance to avoid accusations of trading on material nonpublic information. Regulatory and sector specifics—REIT distribution rules, derivative cross-default clauses and healthcare reimbursement/regulatory shifts—create additional timing risk for trades; researchers should watch for clustered insider sales after the reverse split/tender and for trades ahead of covenant-sensitive disclosures or major tenant announcements.